Michael Mina

Michael Mina, MD, PhD, serves as the Executive Chairman and a member of the Board of Directors at C2Sense, Inc., and holds strategic advisory roles at Sanofi and a scientific advisory board member position at Vital Bio and CorDx. Notably, Michael is a consultant and advisor to Walgreens, providing guidance on pandemic response and diagnostics. Previously, Michael held the title of Chief Science Officer at eMed Digital Healthcare and advised 3M on new diagnostic devices. As co-director of the US NIH Home Test to Treat Program, Michael facilitated the integration of home diagnostics with telemedicine. Michael has an extensive academic background, including post-doctoral work at Harvard and Princeton, residency at Harvard Medical School, and an MD/PhD from Emory University.